MORGAN NARANJO: Open Payments
NPI 1548669526 · LUFKIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 36 payments from 8 companies in 2025. Trend: 2023 $659 · 2024 $967 · 2025 $711
Food & beverage: $666Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $159 |
| AstraZeneca Pharmaceuticals LP | 8 | $158 |
| PFIZER INC. | 4 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $92 |
| Lilly USA, LLC | 2 | $62 |
| Dexcom, Inc. | 1 | $26 |
| Exact Sciences Corporation | 1 | $20 |
Products named: FARXIGA, JARDIANCE, ELIQUIS, Kerendia, Ozempic, Rybelsus, Dexcom G6 Transmitter, BREZTRI.
Industry payments across TX — which companies pay providers there.
